Product logins

Find logins to all Clarivate products below.


: Market Access

Here you will find relevant articles and insight into all Clarivate related products and news.

These six radioligand therapy companies to watch are ushering in a new era of precision oncology These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Blog June 18, 2025
These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Biopharma Clinical research Market Access
Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy
This small biotech notched a big win for rare disease patients with a canny market access strategy This small biotech notched a big win for rare disease patients with a canny market access strategy
Blog December 19, 2024
This small biotech notched a big win for rare disease patients with a canny market access strategy
Market Access
PBM GPO market share shifts as health plan enrollment continues to churn PBM GPO market share shifts as health plan enrollment continues to churn
Blog December 11, 2024
PBM GPO market share shifts as health plan enrollment continues to churn
Market Access
How the U.S. election could impact the healthcare industries How the U.S. election could impact the healthcare industries
Blog October 17, 2024
How the U.S. election could impact the healthcare industries
Market Access Pharma Portfolio strategy
Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot? Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?
Blog September 25, 2024
Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?
Consulting Resource Center Market Access Pharma
Navigating reimbursement and formulary listing discussions: Six tips for more effective objection handling in pharmaceutical market access Navigating reimbursement and formulary listing discussions: Six tips for more effective objection handling in pharmaceutical market access
Blog September 19, 2024
Navigating reimbursement and formulary listing discussions: Six tips for more effective objection handling in pharmaceutical market access
Market Access

Market Access

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
These six radioligand therapy companies to watch are ushering in a new era of precision oncology These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Blog June 18, 2025
These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
This small biotech notched a big win for rare disease patients with a canny market access strategy This small biotech notched a big win for rare disease patients with a canny market access strategy
Blog December 19, 2024
This small biotech notched a big win for rare disease patients with a canny market access strategy
PBM GPO market share shifts as health plan enrollment continues to churn PBM GPO market share shifts as health plan enrollment continues to churn
Blog December 11, 2024
PBM GPO market share shifts as health plan enrollment continues to churn
How the U.S. election could impact the healthcare industries How the U.S. election could impact the healthcare industries
Blog October 17, 2024
How the U.S. election could impact the healthcare industries
Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot? Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?
Blog September 25, 2024
Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?
Navigating reimbursement and formulary listing discussions: Six tips for more effective objection handling in pharmaceutical market access Navigating reimbursement and formulary listing discussions: Six tips for more effective objection handling in pharmaceutical market access
Blog September 19, 2024
Navigating reimbursement and formulary listing discussions: Six tips for more effective objection handling in pharmaceutical market access
After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient
Blog August 28, 2024
After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient
Beyond transparent pricing: decoding the strategies of major PBMs Beyond transparent pricing: decoding the strategies of major PBMs
Blog August 7, 2024
Beyond transparent pricing: decoding the strategies of major PBMs